Evidence map›Paper›PMID 34748562›Full record

ArticlePLoS genetics2021

The FASTK family proteins fine-tune mitochondrial RNA processing.

Akira Ohkubo, Lindsey Van Haute, Danielle L Rudler, Maike Stentenbach, Florian A Steiner, Oliver Rackham, Michal Minczuk, Aleksandra Filipovska, Jean-Claude Martinou

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Central dogma rates in human mitochondria.Human molecular genetics · 2024
    Review
  17. Review
  18. Review
  19. Article
  20. Mechanisms and regulation of human mitochondrial transcription.Nature reviews. Molecular cell biology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Akira OhkuboDepartment of Cell Biology, University of Geneva, Geneva, Switzerland.ORCID 0000-0002-5441-8547
Lindsey Van HauteMedical Research Council Mitochondrial Biology Unit, University of Cambridge, Cambridge, United Kingdom.
Danielle L RudlerHarry Perkins Institute of Medical Research, Queen Elizabeth II Medical Centre, Perth, Australia.ORCID 0000-0002-5540-6548
Maike StentenbachHarry Perkins Institute of Medical Research, Queen Elizabeth II Medical Centre, Perth, Australia.ORCID 0000-0002-1933-9149
Florian A SteinerDepartment of Molecular Biology, University of Geneva, Geneva, Switzerland.ORCID 0000-0002-0514-5060
Oliver RackhamHarry Perkins Institute of Medical Research, Queen Elizabeth II Medical Centre, Perth, Australia.
Michal MinczukMedical Research Council Mitochondrial Biology Unit, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0001-8242-1420
Aleksandra FilipovskaHarry Perkins Institute of Medical Research, Queen Elizabeth II Medical Centre, Perth, Australia.ORCID 0000-0002-6998-8403
Jean-Claude MartinouDepartment of Cell Biology, University of Geneva, Geneva, Switzerland.ORCID 0000-0002-9847-2051
University of Geneva · CHThe Kids Research Institute Australia · AUThe University of Western Australia · AUUniversity of Cambridge · GB

Funding

Medical Research Council MC_UU_00015/4
6 · The paper itself

Abstract

Transcription of the human mitochondrial genome and correct processing of the two long polycistronic transcripts are crucial for oxidative phosphorylation. According to the tRNA punctuation model, nucleolytic processing of these large precursor transcripts occurs mainly through the excision of the tRNAs that flank most rRNAs and mRNAs. However, some mRNAs are not punctuated by tRNAs, and it remains largely unknown how these non-canonical junctions are resolved. The FASTK family proteins are emerging as key players in non-canonical RNA processing. Here, we have generated human cell lines carrying single or combined knockouts of several FASTK family members to investigate their roles in non-canonical RNA processing. The most striking phenotypes were obtained with loss of FASTKD4 and FASTKD5 and with their combined double knockout. Comprehensive mitochondrial transcriptome analyses of these cell lines revealed a defect in processing at several canonical and non-canonical RNA junctions, accompanied by an increase in specific antisense transcripts. Loss of FASTKD5 led to the most severe phenotype with marked defects in mitochondrial translation of key components of the electron transport chain complexes and in oxidative phosphorylation. We reveal that the FASTK protein family members are crucial regulators of non-canonical junction and non-coding mitochondrial RNA processing.

Indexed as

RNA Processing, Post-TranscriptionalCell LineGene Knockout TechniquesHumansMitochondrial ProteinsRNA-Binding ProteinsRNA, MessengerRNA, MitochondrialTranscriptomeMitochondrial ProteinsRNA-Binding ProteinsRNA, MessengerRNA, MitochondrialTBRG4 protein, human

Identifiers

PMID34748562
PMCPMC8601606
OpenAlexW3212129469

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.